StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Lonza Group AG
Swiss Stock Exchange:LONN.SW
Sector
Location
Market Cap
USD 49.30 B
Share Price
USD 701.96
Avg Daily Volume
150,788
Change (1 day)
-0.78%
Change (1 year)
21.82%
Change (YTD)
18.48%
Lonza Group AG Return on Equity (ROE) for the year ending December 31, 2024: 6.82%
Lonza Group AG Return on Equity (ROE) is 6.82% for the year ending December 31, 2024, a -1.46% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
-
Lonza Group AG Return on Equity (ROE) for the year ending December 31, 2023 was 6.92%, a -39.65% change year over year.
-
Lonza Group AG Return on Equity (ROE) for the year ending December 31, 2022 was 11.47%, a -62.03% change year over year.
-
Lonza Group AG Return on Equity (ROE) for the year ending December 31, 2021 was 30.19%, a 136.80% change year over year.
-
Lonza Group AG Return on Equity (ROE) for the year ending December 31, 2020 was 12.75%, a 28.38% change year over year.
Competitors
AbbVie Inc.
USD 186.39
ABBV
-5.13
-2.68%
Roche Holding AG
USD 337.03
RO.SW
-6.82
-1.98%
AstraZeneca PLC
USD 140.43
AZN.L
-2.72
-1.90%
Merck & Co., Inc.
USD 81.52
MRK
-2.15
-2.57%
Amgen Inc.
USD 292.51
AMGN
-4.52
-1.52%
Pfizer Inc.
USD 24.61
PFE
-0.74
-2.92%
Gilead Sciences, Inc.
USD 109.06
GILD
-3.03
-2.70%
Sanofi
USD 95.94
SAN.PA
-1.50
-1.54%
Bristol-Myers Squibb Company
USD 46.43
BMY
-0.91
-1.92%
GSK plc
USD 18.76
GSK.L
-0.36
-1.89%
Chugai Pharmaceutical Co., Ltd.
USD 45.53
4519.T
-0.47
-1.02%
Regeneron Pharmaceuticals, Inc.
USD 547.96
REGN
-22.63
-3.97%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.01
600276.SS
+0.03
0.41%
Takeda Pharmaceutical Company Limited
USD 29.48
4502.T
-0.38
-1.26%
Ucb S.A.
USD 198.03
UCB.BR
-3.24
-1.61%
BeOne Medicines Ltd.
USD 269.70
ONC
+17.56
6.96%
Hansoh Pharmaceutical Group Company Limited
USD 4.25
3692.HK
-0.01
-0.12%
Insmed Incorporated
USD 102.87
INSM
+0.98
0.96%
Summit Therapeutics Inc.
USD 24.36
SMMT
-1.04
-4.09%
Torrent Pharmaceuticals Limited
USD 39.99
TORNTPHARM.NS
+0.39
0.99%
Key Data
| Date | Return on Equity (ROE) | Return on Assets (ROA) | Revenue Per Share | Free Cash Flow Per Share |
|---|
Competitors
AbbVie Inc.
USD 186.39
ABBV
-5.13
-2.68%
Roche Holding AG
USD 337.03
RO.SW
-6.82
-1.98%
AstraZeneca PLC
USD 140.43
AZN.L
-2.72
-1.90%
Merck & Co., Inc.
USD 81.52
MRK
-2.15
-2.57%
Amgen Inc.
USD 292.51
AMGN
-4.52
-1.52%
Pfizer Inc.
USD 24.61
PFE
-0.74
-2.92%
Gilead Sciences, Inc.
USD 109.06
GILD
-3.03
-2.70%
Sanofi
USD 95.94
SAN.PA
-1.50
-1.54%
Bristol-Myers Squibb Company
USD 46.43
BMY
-0.91
-1.92%
GSK plc
USD 18.76
GSK.L
-0.36
-1.89%
Chugai Pharmaceutical Co., Ltd.
USD 45.53
4519.T
-0.47
-1.02%
Regeneron Pharmaceuticals, Inc.
USD 547.96
REGN
-22.63
-3.97%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.01
600276.SS
+0.03
0.41%
Takeda Pharmaceutical Company Limited
USD 29.48
4502.T
-0.38
-1.26%
Ucb S.A.
USD 198.03
UCB.BR
-3.24
-1.61%
BeOne Medicines Ltd.
USD 269.70
ONC
+17.56
6.96%
Hansoh Pharmaceutical Group Company Limited
USD 4.25
3692.HK
-0.01
-0.12%
Insmed Incorporated
USD 102.87
INSM
+0.98
0.96%
Summit Therapeutics Inc.
USD 24.36
SMMT
-1.04
-4.09%
Torrent Pharmaceuticals Limited
USD 39.99
TORNTPHARM.NS
+0.39
0.99%